Hui-Ming Lin

14PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 27, 2026
Insulin-Like Growth Factor Axis and Survival in Metastatic Hormone-Sensitive Prostate Cancer: Post-Hoc Analysis From the ENZAMET Phase 3 Trial.

|Jun 26, 2026
AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial.

|Mar 06, 2026
A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.

Barak Talmor, Stefano Marastoni, Brandon Lau

|Jul 29, 2024
Circulating Lipid Profiles Associated With Resistance to Androgen Deprivation Therapy in Localized Prostate Cancer.

Hui-Ming Lin, Xiaoyu Yang, Margaret M Centenera

|May 01, 2024
Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy.

Nicole Yeung, Tiffany Li, Hui-Ming Lin

|Mar 28, 2024
Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.

Kate L Mahon, Sarah Im Sutherland, Hui Ming Lin

Pageof 3

Frequent Collaborators

6 joint publications

Lisa G Horvath

5 joint publications

Peter J Meikle

5 joint publications

Lisa M Butler

4 joint publications

Anthony M Joshua